Team:NTNU Trondheim/Notebook/August
From 2012.igem.org
(→Notebook/August) |
(→Monday 27.08.12) |
||
(37 intermediate revisions not shown) | |||
Line 1: | Line 1: | ||
{{:Team:NTNU_Trondheim/Templates/Header}} | {{:Team:NTNU_Trondheim/Templates/Header}} | ||
+ | <html> | ||
+ | <div class="container"> | ||
+ | <div class="page-header-top"> | ||
+ | <h1>Notebook <small>August</small></h1> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | <div class="container main-container"> | ||
+ | |||
+ | |||
+ | <div class="row"> | ||
- | = | + | <div class="span10 offset1"> |
+ | </html> | ||
__NOTOC__ | __NOTOC__ | ||
+ | <html><div class="well well-small"></html> | ||
{{:Team:NTNU_Trondheim/Templates/Calendar}} | {{:Team:NTNU_Trondheim/Templates/Calendar}} | ||
+ | <html></div> | ||
+ | |||
+ | </div> | ||
+ | </div> | ||
+ | <div class="row-fluid"> | ||
+ | <div class="span12"> | ||
+ | </html> | ||
+ | |||
+ | ===Monday 27.08.12=== | ||
+ | ---- | ||
+ | |||
+ | Colicin expressed from the K+RBS+Colicin+DTT plasmid was tested on ''E.coli'' DH5α cells. | ||
+ | |||
+ | Also, Plld w/ RBS from ''E.coli'' was cut with S+P, Plld w/RBS from ''C.glutamicum'' was cut with E+P, and linearized plasmid backbone pSB1A3 was cut with E+P. The samples will be purified and ligated tomorrow. | ||
+ | |||
+ | |||
+ | Results from the miniprep: | ||
+ | |||
+ | |||
+ | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" | ||
+ | !Gene | ||
+ | !Concentration [ng/µl] | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr+YFP+DTT in pSB1A3 #1 | ||
+ | |29,5 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr+YFP+DTT in pSB1A3 #2 | ||
+ | |23,7 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr+YFP+DTT in pSB1A3 #3 | ||
+ | |47,7 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr+YFP+DTT in pSB1A3 #4 | ||
+ | |25,2 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr+YFP+DTT in pSB13 #1 | ||
+ | |18,8 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr+YFP+DTT in pSB1C3 #2 | ||
+ | |21,0 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr in pSB1C3 2.1 | ||
+ | |24,8 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr in pSB1C3 2.2 | ||
+ | |20,7 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr in pSB1C3 3.1 | ||
+ | |21,3 | ||
+ | |- | ||
+ | |P<sub>lld</sub>CGr in pSB1C3 3.2 | ||
+ | |18,4 | ||
+ | |- | ||
+ | |} | ||
+ | |||
+ | ===Sunday 26.08.12=== | ||
+ | ---- | ||
+ | |||
+ | RNA was isolated from the RBS(<partinfo>BBa_B0030</partinfo>)+LacI(<partinfo>BBa_C0061</partinfo>)+DTT(<partinfo>BBa_B0014</partinfo>) and ''E.coli'' DH5α cells inoculated friday. RNA was isolated, and the DNAse reaction and the cDNA reaction were performed according to the protocol on the procedures page. The cDNA was frozen down to -80 °C. | ||
+ | |||
+ | |||
+ | ===Friday 24.08.12=== | ||
+ | ---- | ||
+ | |||
+ | Inoculated one cell culture of ''E.coli'' DH5α containing a plasmid consisting of RBS (<partinfo>BBa_B0030</partinfo>) + LacI (<partinfo>BBa_C0061</partinfo>) + DTT (<partinfo>BBa_B0014</partinfo>), and one cell culture consisting of ''E.coli'' DH5α cells without plasmid. These colonies will be used for real time PCR. | ||
+ | |||
+ | ===Thursday 23.08.12=== | ||
+ | ---- | ||
+ | |||
+ | BBa_K822001 in pSB1A3 was cut with Spe1 and Pst1, BBa_E0030 + terminator was cut with Xba1 and PSt1. | ||
+ | |||
+ | BBa_E0030 + terminator was run on gel, and got the consentration 4,5 ng/uL. | ||
+ | |||
+ | BBa_K822001 in pSB1A3 was purified using a PCR purifying kit, and an concentration of 1,2 ng/uL was obtained. | ||
+ | |||
+ | ===Wednesday 22.08.12=== | ||
+ | ---- | ||
+ | |||
+ | P<sub>lld</sub> in pSB1A3 and pSB1C3 were miniprepped as described in the [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocol]. The concentrations are listed below. | ||
+ | |||
+ | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" | ||
+ | !Gene | ||
+ | !Concentration [ng/µl] | ||
+ | |- | ||
+ | |P<sub>lld</sub> in pSB1A3 | ||
+ | |25,7 | ||
+ | |- | ||
+ | |P<sub>lld</sub> in pSB1C3 | ||
+ | |39,5 | ||
+ | |- | ||
+ | |} | ||
+ | |||
+ | |||
+ | ===Tuesday 21.08.12=== | ||
+ | ---- | ||
+ | |||
+ | The primers ordered came today, so PCR was performed on p<sub>lld</sub> with RBS (from ''Corynebacterium glutamicum''), lldR from ''E. coli'' and ''C. glutamicum'', and His-tagged lld from ''C. glutamicum''. | ||
+ | |||
+ | The PCR mix and program are given below. | ||
+ | |||
+ | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" | ||
+ | !Substance | ||
+ | !Volume [µl] | ||
+ | |- | ||
+ | |dH<sub>2</sub>O | ||
+ | |32,5 | ||
+ | |- | ||
+ | |5x-buffer | ||
+ | |10,0 | ||
+ | |- | ||
+ | |dNTPs | ||
+ | |1,0 | ||
+ | |- | ||
+ | |fwd primer | ||
+ | |2,5 | ||
+ | |- | ||
+ | |rev primer | ||
+ | |2,5 | ||
+ | |- | ||
+ | |template | ||
+ | |1,0 | ||
+ | |- | ||
+ | |Phusion polymerase | ||
+ | |0,5 | ||
+ | |- | ||
+ | |} | ||
+ | |||
+ | The addition of the Phusion polymerase is done immediately before starting the PCR program. | ||
+ | |||
+ | {| | ||
+ | | style="padding-right:7px;" | | ||
+ | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" | ||
+ | ! Step | ||
+ | ! Action | ||
+ | ! Temperature [°C] | ||
+ | ! Duration | ||
+ | |- | ||
+ | |1 | ||
+ | |Heated lid | ||
+ | |103 | ||
+ | | | ||
+ | |- | ||
+ | |2 | ||
+ | |Initial denaturation | ||
+ | |98 | ||
+ | |30 sek | ||
+ | |- | ||
+ | |3 | ||
+ | |Denaturation | ||
+ | |98 | ||
+ | |10 sek | ||
+ | |- | ||
+ | |4 | ||
+ | |Annealing | ||
+ | |x<sub>1</sub> | ||
+ | |30 sek | ||
+ | |- | ||
+ | |5 | ||
+ | |Elongation | ||
+ | |72 | ||
+ | |x<sub>2</sub> | ||
+ | |- | ||
+ | |6 | ||
+ | |Go to step 3, repeat 10 x | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |7 | ||
+ | |Denaturation | ||
+ | |98 | ||
+ | |10 sek | ||
+ | |- | ||
+ | |8 | ||
+ | |Elongation | ||
+ | |72 | ||
+ | |x<sub>2</sub> | ||
+ | |- | ||
+ | |9 | ||
+ | |Go to step 7, repeat 15 x, with 5 s extra each time | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |10 | ||
+ | |Final Elongation | ||
+ | |72 | ||
+ | |5 min | ||
+ | |- | ||
+ | |11 | ||
+ | |Hold | ||
+ | |4 | ||
+ | |∞ | ||
+ | |} | ||
+ | |||
+ | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" | ||
+ | !Amplicon | ||
+ | !x<sub>1</sub> [°C] | ||
+ | !x<sub>2</sub> [s] | ||
+ | |- | ||
+ | |His tagged lld, ''C. glutamicum'' | ||
+ | |62 | ||
+ | |60 | ||
+ | |- | ||
+ | |P<sub>lld</sub>, ''C. glutamicum'' | ||
+ | |63 | ||
+ | |5 | ||
+ | |- | ||
+ | |lldR, ''E. coli'' | ||
+ | | - | ||
+ | |26 | ||
+ | |- | ||
+ | |lldR, ''C. glutamicum'' | ||
+ | |66 | ||
+ | |21 | ||
+ | |- | ||
+ | |} | ||
+ | |||
+ | ===Monday 20.08.12=== | ||
+ | ---- | ||
+ | |||
+ | P<sub>lld</sub> in pSB1A3 was transformed into DH5α cells an plated out. Incubated at 37 °C. | ||
+ | The cells inoculated to liquid medium on saturday were miniprepped. The concentrations are given below, together with the volume necessary for obtaining 1000 ng of plasmid | ||
+ | |||
+ | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" | ||
+ | !Biobrick | ||
+ | !Concentration [ng/µl] | ||
+ | !Volume required to obtain 1000 ng plasmid | ||
+ | |- | ||
+ | |Vgb+RBS+YFP+DTT | ||
+ | |27.1 | ||
+ | |36.9 | ||
+ | |- | ||
+ | |Vgb+RBS+LuxR+DTT | ||
+ | |32.1 | ||
+ | |31.2 | ||
+ | |- | ||
+ | |K+RBS+colicin | ||
+ | |28.4 | ||
+ | |35.2 | ||
+ | |- | ||
+ | |<partinfo>BBa_K292006</partinfo> | ||
+ | |26.0 | ||
+ | |38.5 | ||
+ | |- | ||
+ | |Colicin in pSB1C3 | ||
+ | |35.3 | ||
+ | |28.3 | ||
+ | |- | ||
+ | |YFP+DTT | ||
+ | |39.6 | ||
+ | |25.3 | ||
+ | |- | ||
+ | |RBS*+LacI+DTT* | ||
+ | |33.0 | ||
+ | |30.3 | ||
+ | |} | ||
+ | |||
+ | The required volume for obtaining 1000 ng of plasmid were then pipetted out for each sample, and dried on a heat block prewarmed to 50 °C, to obtain an approximate volume of 15 µl. | ||
+ | The samples were then sent to sequencing. | ||
+ | |||
+ | |||
+ | ===Saturday 18.08.12=== | ||
+ | ---- | ||
+ | |||
+ | P<sub>lld</sub> cut with E+P and <partinfo>pSB1A3</partinfo> cut with E+P was ligated together to see if the P<sub>lld</sub> promoter will be more functional in an ampicillin plasmid. | ||
+ | In order to be able to send plasmids to sequencing on monday, Vgb+RBS+YFP+DTT, Vgb+RBS+LuxR+DTT, K+RBS+colicin, <partinfo>BBa_K292006</partinfo>, colicin in pSB1C3, YFP+DTT and RBS*+LacI+DTT* was inoculated to liquid medium | ||
+ | |||
+ | |||
+ | ===Thursday 16.08.12=== | ||
+ | ---- | ||
+ | |||
+ | P<sub>lld</sub>+lysis and pSB1A3 cut yesterday with E+P was investigated on gel. Two fragments were obtained for P<sub>lld</sub>+lysis, but the sizes of the fragments were not as expected. Since we are not sure which fragment is which, both of the fragments were cut out of the gel and purified using the QIAquick gel extraction kit. In case one of them is uncut plasmid, the unligated DNA from both bonds will be transformed tomorrow, and we will assume that if the cells transformed with DNA from one of the samples won't grow, that sample will contain digested plasmid. This sample will be ligated with pSB1A3, plated out on a ampicillin plate, and then, several cell cultures from this plate will be plated out on a chloramphenicol plate. The colonies that won't grow on chloramphenicol, is assumed to contain the correct plasmid. | ||
+ | |||
+ | Vgb+RBS religated, Vgb+RBS+LuxR+DTT #1, Vgb+RBS+LuxR+DTT #2, LuxI+DTT, K+RBS+LacI+DTT and his-tagged LldR was miniprepped using the Promega SV miniprep kit. The concentrations of isolated plasmid are given below: | ||
+ | |||
+ | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" | ||
+ | !Plasmid | ||
+ | !Concentration [ng/µl] | ||
+ | |- | ||
+ | |Vgb+RBS religated | ||
+ | |27.3 | ||
+ | |- | ||
+ | |Vgb+RBS+LuxR+DTT #1 | ||
+ | |26.2 | ||
+ | |- | ||
+ | |Vgb+RBS+LuxR+DTT #2 | ||
+ | |31.7 | ||
+ | |- | ||
+ | |LuxI+DTT | ||
+ | |35.3 | ||
+ | |- | ||
+ | |K+RBS+LacI+DTT | ||
+ | |7.9 | ||
+ | |- | ||
+ | |his-LldR | ||
+ | |51.0 | ||
+ | |} | ||
+ | |||
+ | Also, Vgb and Vhb was tested again, and Ove named two of the agar plates Mark and Doggie:-) | ||
+ | |||
+ | ===Wednesday 15.08.12=== | ||
+ | ---- | ||
+ | |||
+ | The high expression plasmid containing his-tagged LldR was transferred to liquid medium. | ||
+ | |||
+ | K+RBS+Colicin and the negative colicin control, LuxR+DTT was transferred to new liquid medium in order to be tested. 50 µl of the old cultures was transferred to 10 ml of LB containing ampicillin. | ||
+ | |||
+ | Since we have read that chloramphenicol can be a problem for the lld promoter, we also decided to transfer this brick to a new backbone before further testing. Both P<sub>lld</sub> and P<sub>lld</sub>+RBS+lysis was cut with EcoRI and PstI. Linearized plasmid backbone pSB1A3 was also cut with EcoRI and PstI. Ligations will be performed tomorrow. | ||
+ | |||
===Tuesday 14.08.12=== | ===Tuesday 14.08.12=== | ||
---- | ---- | ||
- | To check | + | To check if the new restriction digest were ok, LuxI (<partinfo>Bba_C0061</partinfo>) and LuxR+term (<partinfo>BBa_C0062</partinfo>, <partinfo>BBa_B0015</partinfo>) were tested with gel electrophoresis. |
+ | |||
[[File:LuxI LuxR+term, 14.08.12exp.png|thumb|center|300px|Picture of gel electrophoresis. LuxI and LuxR+Term cut with NotI, and LuxI and LuxR+term cut with E+S and X+P, respectively.]] | [[File:LuxI LuxR+term, 14.08.12exp.png|thumb|center|300px|Picture of gel electrophoresis. LuxI and LuxR+Term cut with NotI, and LuxI and LuxR+term cut with E+S and X+P, respectively.]] | ||
+ | |||
+ | |||
+ | Cut of the parts consisting the genes, LuxI (<partinfo>Bba_C0061</partinfo>) and LuxR+term (<partinfo>BBa_C0062</partinfo>, <partinfo>BBa_B0015</partinfo>), and extracted the DNA from the gel. Concentrations are listed below. | ||
+ | |||
+ | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" | ||
+ | !BioBrick | ||
+ | !Enzymes | ||
+ | !Concentration [ng/µl] | ||
+ | |- | ||
+ | |LuxI | ||
+ | |EcoRI+SpeI | ||
+ | |4.2 | ||
+ | |- | ||
+ | |LuxR+term | ||
+ | |XbaI+PstI | ||
+ | |5.6 | ||
+ | |- | ||
+ | |} | ||
+ | |||
+ | Ligation mixes were made according to [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocol] with the following ingredients, as well as religation of the backbones: | ||
+ | |||
+ | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" | ||
+ | !Backbone | ||
+ | !Insert | ||
+ | !Plasmid | ||
+ | |- | ||
+ | |K <partinfo>BBa_J23119</partinfo> | ||
+ | |RBS+LacI+term <partinfo>BBa_B0030</partinfo>, <partinfo>Bba_C0012</partinfo>, <partinfo>BBa_B0015</partinfo> | ||
+ | |<partinfo>psB1A2</partinfo> | ||
+ | |- | ||
+ | |Vgb+RBS <partinfo>BBa_K561001</partinfo>, <partinfo>BBa_B0034</partinfo> | ||
+ | |LuxR+term <partinfo>BBa_C0062</partinfo>, <partinfo>BBa_B0015</partinfo> | ||
+ | |<partinfo>psB1A2</partinfo> | ||
+ | |- | ||
+ | |term <partinfo>BBa_B0015</partinfo> | ||
+ | |LuxI <partinfo>BBa_C0061</partinfo> | ||
+ | |<partinfo>pSB1AK3</partinfo> | ||
+ | |- | ||
+ | |} | ||
+ | |||
+ | These were then transformed in competent DH5ɑ cells, as described in the [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocol]. The petri dishes (all with Ampicillin) were left in the incubator over night. | ||
+ | |||
+ | 10 µl of the liquid cultures for K+RBS+colicin and LuxR+DTT was transferred to 5 ml of new liquid medium to be used in testing of the colicin biobrick. The rest of the samples were miniprepped using the Promega SV Miniprep kit. The concentrations of the samples are given below: | ||
+ | |||
+ | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" | ||
+ | !Biobrick | ||
+ | !Concentration [ng/µl] | ||
+ | |- | ||
+ | |K+RBS+colicin | ||
+ | |31.1 | ||
+ | |- | ||
+ | |LuxR+DTT | ||
+ | |31.3 | ||
+ | |} | ||
+ | |||
+ | We also recieved the high expression plasmid for his-tagged LldR today. This was transformed to competent ''E.coli'' K-12 ER2566 cells, as ''E.coli'' Dh5α, which are the cells we normally use in transformation, are unsuited when working with expression of proteins. | ||
===Monday 13.08.12=== | ===Monday 13.08.12=== | ||
Line 20: | Line 398: | ||
Did a restriction digest on the following biobricks, as described in the [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocol]. | Did a restriction digest on the following biobricks, as described in the [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocol]. | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Biobricks | !Biobricks | ||
!BioBrick no. | !BioBrick no. | ||
Line 55: | Line 433: | ||
The concentrations on the purified parts are as follows: | The concentrations on the purified parts are as follows: | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Biobricks | !Biobricks | ||
!BioBrick no. | !BioBrick no. | ||
Line 85: | Line 463: | ||
The concentrations were as follows: | The concentrations were as follows: | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Biobrick | !Biobrick | ||
!Concentration ng/uL | !Concentration ng/uL | ||
Line 116: | Line 494: | ||
The following primers were used: | The following primers were used: | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Primer | !Primer | ||
!Sequence | !Sequence | ||
Line 128: | Line 506: | ||
The PCR machine was programmed according to the following table: | The PCR machine was programmed according to the following table: | ||
- | {| class=" | + | |
+ | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" | ||
!Step | !Step | ||
!Action | !Action | ||
Line 180: | Line 559: | ||
Performed miniprep on RBS (<partinfo>BBa_B0030</partinfo>) and plld+RBS. The concentration were as follows: | Performed miniprep on RBS (<partinfo>BBa_B0030</partinfo>) and plld+RBS. The concentration were as follows: | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Biobrick | !Biobrick | ||
!Concentration ng/uL | !Concentration ng/uL | ||
Line 194: | Line 573: | ||
Did a restriction digest as described in the [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocol] on the following parts. On the pieces to be used as inserts, the number of base pairs are also listed. | Did a restriction digest as described in the [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocol] on the following parts. On the pieces to be used as inserts, the number of base pairs are also listed. | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Biobrick/Construct | !Biobrick/Construct | ||
!BioBrick | !BioBrick | ||
Line 263: | Line 642: | ||
Ligated together the following, as described in [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocols]: | Ligated together the following, as described in [https://2012.igem.org/Team:NTNU_Trondheim/Protocols protocols]: | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Ligation # | !Ligation # | ||
!Backbone | !Backbone | ||
Line 284: | Line 663: | ||
3A assembly was used on the following parts, as described in the [https://2011.igem.org/Team:Northwestern/Notebook/Protocols/3A_Assembly Protocol], by Northwestern University: | 3A assembly was used on the following parts, as described in the [https://2011.igem.org/Team:Northwestern/Notebook/Protocols/3A_Assembly Protocol], by Northwestern University: | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Ligation # | !Ligation # | ||
!Backbone | !Backbone | ||
Line 336: | Line 715: | ||
Miniprepped VHB+RBS+lysis (<partinfo>BBa_K258005</partinfo>, <partinfo>BBa_B0034</partinfo> and <partinfo>BBa_K112808</partinfo>), VGB+RBS+lysis (<partinfo>BBa_K561001</partinfo>, <partinfo>BBa_B0034</partinfo> and <partinfo>BBa_K112808</partinfo>), pllD+lysis (lactate promoter and <partinfo>BBa_K112808</partinfo>) and three parallels of pBad+YFP (<partinfo>Bba_K206000</partinfo> and <partinfo>BBa_E0030</partinfo>) | Miniprepped VHB+RBS+lysis (<partinfo>BBa_K258005</partinfo>, <partinfo>BBa_B0034</partinfo> and <partinfo>BBa_K112808</partinfo>), VGB+RBS+lysis (<partinfo>BBa_K561001</partinfo>, <partinfo>BBa_B0034</partinfo> and <partinfo>BBa_K112808</partinfo>), pllD+lysis (lactate promoter and <partinfo>BBa_K112808</partinfo>) and three parallels of pBad+YFP (<partinfo>Bba_K206000</partinfo> and <partinfo>BBa_E0030</partinfo>) | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Sample | !Sample | ||
!Concentration [ng/µl] | !Concentration [ng/µl] | ||
Line 424: | Line 803: | ||
The constructs containing plld ligated with the lysis device(<partinfo>BBa_K112808</partinfo>), and plld in plasmid <partinfo>PSB1C3</partinfo> were miniprepped. The concentration were measured using nano drop. | The constructs containing plld ligated with the lysis device(<partinfo>BBa_K112808</partinfo>), and plld in plasmid <partinfo>PSB1C3</partinfo> were miniprepped. The concentration were measured using nano drop. | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Sample | !Sample | ||
!Concentration [ng/µl] | !Concentration [ng/µl] | ||
Line 454: | Line 833: | ||
PCR was performed on pBad (<partinfo>Bba_K206000</partinfo>) and DTT (<partinfo>BBa_B0015</partinfo>), the primers used, PCR-mix and programmed times are listed below. | PCR was performed on pBad (<partinfo>Bba_K206000</partinfo>) and DTT (<partinfo>BBa_B0015</partinfo>), the primers used, PCR-mix and programmed times are listed below. | ||
- | {| class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
!Primer | !Primer | ||
!Type | !Type | ||
Line 504: | Line 883: | ||
{| | {| | ||
| style="padding-right:7px;" | | | style="padding-right:7px;" | | ||
- | {|class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
|+pBAD | |+pBAD | ||
! Step | ! Step | ||
Line 565: | Line 944: | ||
| style="padding-left:7px;" | | | style="padding-left:7px;" | | ||
- | {|class=" | + | {|class="table table-bordered table-hover" style="margin: 1em auto 1em auto; width: auto;" |
|+ DTT | |+ DTT | ||
! Step | ! Step | ||
Line 622: | Line 1,001: | ||
|4°C | |4°C | ||
|∞ | |∞ | ||
+ | |} | ||
|} | |} | ||
|} | |} | ||
- | </div> | + | |
+ | {{:Team:NTNU_Trondheim/Templates/Sponsors}} | ||
+ | <html> | ||
+ | </div></div></div></html> | ||
+ | {{:Team:NTNU_Trondheim/Templates/Footer}} |
Latest revision as of 22:03, 26 September 2012